Tracking of epigenetic changes during hematopoietic differentiation of induced pluripotent stem cells.
DNA methylation
Epigenetic
Hematopoiesis
Hematopoietic differentiation
Induced pluripotent stem cells
Mesenchymal stromal cells
Stromal support
Journal
Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977
Informations de publication
Date de publication:
04 02 2019
04 02 2019
Historique:
received:
05
11
2018
accepted:
17
01
2019
entrez:
6
2
2019
pubmed:
6
2
2019
medline:
21
8
2019
Statut:
epublish
Résumé
Differentiation of induced pluripotent stem cells (iPSCs) toward hematopoietic progenitor cells (HPCs) raises high hopes for disease modeling, drug screening, and cellular therapy. Various differentiation protocols have been established to generate iPSC-derived HPCs (iHPCs) that resemble their primary counterparts in morphology and immunophenotype, whereas a systematic epigenetic comparison was yet elusive. In this study, we compared genome-wide DNA methylation (DNAm) patterns of iHPCs with various different hematopoietic subsets. After 20 days of in vitro differentiation, cells revealed typical hematopoietic morphology, CD45 expression, and colony-forming unit (CFU) potential. DNAm changes were particularly observed in genes that are associated with hematopoietic differentiation. On the other hand, the epigenetic profiles of iHPCs remained overall distinct from natural HPCs. Furthermore, we analyzed if additional co-culture for 2 weeks with syngenic primary mesenchymal stromal cells (MSCs) or iPSC-derived MSCs (iMSCs) further supports epigenetic maturation toward the hematopoietic lineage. Proliferation of iHPCs and maintenance of CFU potential was enhanced upon co-culture. However, DNAm profiles support the notion that additional culture expansion with stromal support did not increase epigenetic maturation of iHPCs toward natural HPCs. Differentiation of iPSCs toward the hematopoietic lineage remains epigenetically incomplete. These results substantiate the need to elaborate advanced differentiation regimen while DNAm profiles provide a suitable measure to track this process.
Sections du résumé
BACKGROUND
Differentiation of induced pluripotent stem cells (iPSCs) toward hematopoietic progenitor cells (HPCs) raises high hopes for disease modeling, drug screening, and cellular therapy. Various differentiation protocols have been established to generate iPSC-derived HPCs (iHPCs) that resemble their primary counterparts in morphology and immunophenotype, whereas a systematic epigenetic comparison was yet elusive.
RESULTS
In this study, we compared genome-wide DNA methylation (DNAm) patterns of iHPCs with various different hematopoietic subsets. After 20 days of in vitro differentiation, cells revealed typical hematopoietic morphology, CD45 expression, and colony-forming unit (CFU) potential. DNAm changes were particularly observed in genes that are associated with hematopoietic differentiation. On the other hand, the epigenetic profiles of iHPCs remained overall distinct from natural HPCs. Furthermore, we analyzed if additional co-culture for 2 weeks with syngenic primary mesenchymal stromal cells (MSCs) or iPSC-derived MSCs (iMSCs) further supports epigenetic maturation toward the hematopoietic lineage. Proliferation of iHPCs and maintenance of CFU potential was enhanced upon co-culture. However, DNAm profiles support the notion that additional culture expansion with stromal support did not increase epigenetic maturation of iHPCs toward natural HPCs.
CONCLUSION
Differentiation of iPSCs toward the hematopoietic lineage remains epigenetically incomplete. These results substantiate the need to elaborate advanced differentiation regimen while DNAm profiles provide a suitable measure to track this process.
Identifiants
pubmed: 30717806
doi: 10.1186/s13148-019-0617-1
pii: 10.1186/s13148-019-0617-1
pmc: PMC6360658
doi:
Substances chimiques
Leukocyte Common Antigens
EC 3.1.3.48
PTPRC protein, human
EC 3.1.3.48
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
19Références
Stem Cells Dev. 2014 Jul 15;23(14):1594-610
pubmed: 24625206
Nat Rev Mol Cell Biol. 2017 Jan;18(1):56-67
pubmed: 27876786
Nat Genet. 2012 Nov;44(11):1236-42
pubmed: 23064414
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Exp Hematol. 2011 Jun;39(6):617-28
pubmed: 21356269
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Epigenetics. 2014 Aug;9(8):1108-19
pubmed: 24866170
PLoS One. 2011 Feb 08;6(2):e16679
pubmed: 21347436
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Genome Res. 2013 Feb;23(2):248-59
pubmed: 23080539
Blood. 2013 Dec 12;122(25):4035-46
pubmed: 24124087
Bone Marrow Transplant. 2006 Feb;37(4):359-66
pubmed: 16400333
Nat Genet. 2009 Nov;41(11):1207-15
pubmed: 19801979
Biomaterials. 2018 Feb;156:147-158
pubmed: 29197223
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
PLoS One. 2008 May 21;3(5):e2213
pubmed: 18493317
Nature. 2008 Aug 7;454(7205):766-70
pubmed: 18600261
PLoS One. 2012;7(7):e41361
pubmed: 22848472
Cytotherapy. 2007;9(4):338-47
pubmed: 17573609
Genome Biol. 2014 Feb 20;15(2):R37
pubmed: 24555846
Stem Cell Reports. 2014 Sep 9;3(3):414-22
pubmed: 25241740
Cell Rep. 2012 Dec 27;2(6):1722-35
pubmed: 23219550
Stem Cells Transl Med. 2016 Nov;5(11):1447-1460
pubmed: 27400789
Genome Biol. 2014 Feb 03;15(2):R24
pubmed: 24490752
Cell Stem Cell. 2014 Oct 2;15(4):507-522
pubmed: 25158935
Sci Rep. 2013 Nov 28;3:3372
pubmed: 24284763
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2180-2185
pubmed: 29386396
Sci Rep. 2015 Mar 10;5:8973
pubmed: 25754700
Cytotherapy. 2013 Sep;15(9):1174-81
pubmed: 23845186
Cell Stem Cell. 2016 Dec 1;19(6):808-822
pubmed: 27867036
Cell Stem Cell. 2016 Sep 1;19(3):341-54
pubmed: 27476965
Nucleic Acids Res. 2012 Dec;40(22):11339-51
pubmed: 23074194
Stem Cells. 2017 Apr;35(4):898-908
pubmed: 28090699
Mol Med. 2016 Sep;22:274-285
pubmed: 27262025
BMC Genomics. 2015 Sep 29;16:736
pubmed: 26419829
Haematologica. 2015 Jan;100(1):32-41
pubmed: 25326431
Clin Chem. 2018 Mar;64(3):566-575
pubmed: 29118064
Circ Res. 2015 Jun 19;117(1):17-28
pubmed: 25904599
J Hematol Oncol. 2016 Apr 21;9:43
pubmed: 27098268
PLoS One. 2013 May 29;8(5):e65324
pubmed: 23734247
Stem Cell Res. 2018 May;29:232-244
pubmed: 29751281
Nat Methods. 2011 May;8(5):409-12
pubmed: 21460823
Stem Cells. 2018 Jul;36(7):1004-1019
pubmed: 29569827
Stem Cell Reports. 2015 Feb 10;4(2):282-96
pubmed: 25680479
Epigenetics. 2011 Jun;6(6):692-702
pubmed: 21593595
BMC Bioinformatics. 2005 Jul 05;6:168
pubmed: 15998470
Bone Marrow Transplant. 2013 Aug;48(8):1040-5
pubmed: 23396407
J Cell Mol Med. 2010 Jan;14(1-2):337-50
pubmed: 19432817
Nature. 2017 May 25;545(7655):432-438
pubmed: 28514439
EMBO Mol Med. 2015 Jul 14;7(11):1388-402
pubmed: 26174486
Stem Cells. 2007 Oct;25(10):2638-47
pubmed: 17615262
Cytotherapy. 2010 Nov;12(7):888-98
pubmed: 20662607